Copyright Reports & Markets. All rights reserved.

Global Necrotic Enteritis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Necrotic Enteritis Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Route
    • 1.3.1 Overview: Global Necrotic Enteritis Treatment Consumption Value by Route: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral
    • 1.3.3 Parenteral
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Necrotic Enteritis Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Home
  • 1.5 Global Necrotic Enteritis Treatment Market Size & Forecast
    • 1.5.1 Global Necrotic Enteritis Treatment Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Necrotic Enteritis Treatment Sales Quantity (2018-2029)
    • 1.5.3 Global Necrotic Enteritis Treatment Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Prometic Life Sciences Inc.
    • 2.1.1 Prometic Life Sciences Inc. Details
    • 2.1.2 Prometic Life Sciences Inc. Major Business
    • 2.1.3 Prometic Life Sciences Inc. Necrotic Enteritis Treatment Product and Services
    • 2.1.4 Prometic Life Sciences Inc. Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Prometic Life Sciences Inc. Recent Developments/Updates
  • 2.2 BioGaia Probiotics
    • 2.2.1 BioGaia Probiotics Details
    • 2.2.2 BioGaia Probiotics Major Business
    • 2.2.3 BioGaia Probiotics Necrotic Enteritis Treatment Product and Services
    • 2.2.4 BioGaia Probiotics Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BioGaia Probiotics Recent Developments/Updates
  • 2.3 Fresenius Kabi AG
    • 2.3.1 Fresenius Kabi AG Details
    • 2.3.2 Fresenius Kabi AG Major Business
    • 2.3.3 Fresenius Kabi AG Necrotic Enteritis Treatment Product and Services
    • 2.3.4 Fresenius Kabi AG Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Fresenius Kabi AG Recent Developments/Updates
  • 2.4 Actavis Plc.
    • 2.4.1 Actavis Plc. Details
    • 2.4.2 Actavis Plc. Major Business
    • 2.4.3 Actavis Plc. Necrotic Enteritis Treatment Product and Services
    • 2.4.4 Actavis Plc. Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Actavis Plc. Recent Developments/Updates
  • 2.5 Bayer International
    • 2.5.1 Bayer International Details
    • 2.5.2 Bayer International Major Business
    • 2.5.3 Bayer International Necrotic Enteritis Treatment Product and Services
    • 2.5.4 Bayer International Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bayer International Recent Developments/Updates
  • 2.6 Alcon Laboratories, Inc.
    • 2.6.1 Alcon Laboratories, Inc. Details
    • 2.6.2 Alcon Laboratories, Inc. Major Business
    • 2.6.3 Alcon Laboratories, Inc. Necrotic Enteritis Treatment Product and Services
    • 2.6.4 Alcon Laboratories, Inc. Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Alcon Laboratories, Inc. Recent Developments/Updates
  • 2.7 Bausch & Lomb Incorporated
    • 2.7.1 Bausch & Lomb Incorporated Details
    • 2.7.2 Bausch & Lomb Incorporated Major Business
    • 2.7.3 Bausch & Lomb Incorporated Necrotic Enteritis Treatment Product and Services
    • 2.7.4 Bausch & Lomb Incorporated Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Bausch & Lomb Incorporated Recent Developments/Updates
  • 2.8 GlaxoSmithKline plc.
    • 2.8.1 GlaxoSmithKline plc. Details
    • 2.8.2 GlaxoSmithKline plc. Major Business
    • 2.8.3 GlaxoSmithKline plc. Necrotic Enteritis Treatment Product and Services
    • 2.8.4 GlaxoSmithKline plc. Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 GlaxoSmithKline plc. Recent Developments/Updates
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Necrotic Enteritis Treatment Product and Services
    • 2.9.4 Pfizer Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Pfizer Recent Developments/Updates
  • 2.10 Transo-Pharm
    • 2.10.1 Transo-Pharm Details
    • 2.10.2 Transo-Pharm Major Business
    • 2.10.3 Transo-Pharm Necrotic Enteritis Treatment Product and Services
    • 2.10.4 Transo-Pharm Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Transo-Pharm Recent Developments/Updates
  • 2.11 Rochem International
    • 2.11.1 Rochem International Details
    • 2.11.2 Rochem International Major Business
    • 2.11.3 Rochem International Necrotic Enteritis Treatment Product and Services
    • 2.11.4 Rochem International Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Rochem International Recent Developments/Updates
  • 2.12 HELM Portugal
    • 2.12.1 HELM Portugal Details
    • 2.12.2 HELM Portugal Major Business
    • 2.12.3 HELM Portugal Necrotic Enteritis Treatment Product and Services
    • 2.12.4 HELM Portugal Necrotic Enteritis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 HELM Portugal Recent Developments/Updates

3 Competitive Environment: Necrotic Enteritis Treatment by Manufacturer

  • 3.1 Global Necrotic Enteritis Treatment Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Necrotic Enteritis Treatment Revenue by Manufacturer (2018-2023)
  • 3.3 Global Necrotic Enteritis Treatment Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Necrotic Enteritis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Necrotic Enteritis Treatment Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Necrotic Enteritis Treatment Manufacturer Market Share in 2022
  • 3.5 Necrotic Enteritis Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Necrotic Enteritis Treatment Market: Region Footprint
    • 3.5.2 Necrotic Enteritis Treatment Market: Company Product Type Footprint
    • 3.5.3 Necrotic Enteritis Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Necrotic Enteritis Treatment Market Size by Region
    • 4.1.1 Global Necrotic Enteritis Treatment Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Necrotic Enteritis Treatment Consumption Value by Region (2018-2029)
    • 4.1.3 Global Necrotic Enteritis Treatment Average Price by Region (2018-2029)
  • 4.2 North America Necrotic Enteritis Treatment Consumption Value (2018-2029)
  • 4.3 Europe Necrotic Enteritis Treatment Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Necrotic Enteritis Treatment Consumption Value (2018-2029)
  • 4.5 South America Necrotic Enteritis Treatment Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Necrotic Enteritis Treatment Consumption Value (2018-2029)

5 Market Segment by Route

  • 5.1 Global Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 5.2 Global Necrotic Enteritis Treatment Consumption Value by Route (2018-2029)
  • 5.3 Global Necrotic Enteritis Treatment Average Price by Route (2018-2029)

6 Market Segment by Application

  • 6.1 Global Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 6.2 Global Necrotic Enteritis Treatment Consumption Value by Application (2018-2029)
  • 6.3 Global Necrotic Enteritis Treatment Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 7.2 North America Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 7.3 North America Necrotic Enteritis Treatment Market Size by Country
    • 7.3.1 North America Necrotic Enteritis Treatment Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Necrotic Enteritis Treatment Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 8.2 Europe Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 8.3 Europe Necrotic Enteritis Treatment Market Size by Country
    • 8.3.1 Europe Necrotic Enteritis Treatment Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Necrotic Enteritis Treatment Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 9.2 Asia-Pacific Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Necrotic Enteritis Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Necrotic Enteritis Treatment Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Necrotic Enteritis Treatment Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 10.2 South America Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 10.3 South America Necrotic Enteritis Treatment Market Size by Country
    • 10.3.1 South America Necrotic Enteritis Treatment Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Necrotic Enteritis Treatment Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Necrotic Enteritis Treatment Sales Quantity by Route (2018-2029)
  • 11.2 Middle East & Africa Necrotic Enteritis Treatment Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Necrotic Enteritis Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Necrotic Enteritis Treatment Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Necrotic Enteritis Treatment Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Necrotic Enteritis Treatment Market Drivers
  • 12.2 Necrotic Enteritis Treatment Market Restraints
  • 12.3 Necrotic Enteritis Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Necrotic Enteritis Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Necrotic Enteritis Treatment
  • 13.3 Necrotic Enteritis Treatment Production Process
  • 13.4 Necrotic Enteritis Treatment Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Necrotic Enteritis Treatment Typical Distributors
  • 14.3 Necrotic Enteritis Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Necrotic Enteritis Treatment market size was valued at USD 25720 million in 2022 and is forecast to a readjusted size of USD 40500 million by 2029 with a CAGR of 6.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Necrotic enteritis is an enteric disease of poultry characterized by patches of necrotic tissue on the intestinal epithelium. This disease can cause high mortality, primarily in juvenile broilers.
    This report is a detailed and comprehensive analysis for global Necrotic Enteritis Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Necrotic Enteritis Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Necrotic Enteritis Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Necrotic Enteritis Treatment market size and forecasts, by Route and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Necrotic Enteritis Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Necrotic Enteritis Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Necrotic Enteritis Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc. and Bayer International, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Necrotic Enteritis Treatment market is split by Route and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Route
    Oral
    Parenteral
    Market segment by Application
    Hospital
    Clinic
    Home
    Major players covered
    Prometic Life Sciences Inc.
    BioGaia Probiotics
    Fresenius Kabi AG
    Actavis Plc.
    Bayer International
    Alcon Laboratories, Inc.
    Bausch & Lomb Incorporated
    GlaxoSmithKline plc.
    Pfizer
    Transo-Pharm
    Rochem International
    HELM Portugal
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Necrotic Enteritis Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Necrotic Enteritis Treatment, with price, sales, revenue and global market share of Necrotic Enteritis Treatment from 2018 to 2023.
    Chapter 3, the Necrotic Enteritis Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Necrotic Enteritis Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Route and application, with sales market share and growth rate by route, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Necrotic Enteritis Treatment market forecast, by regions, route and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Necrotic Enteritis Treatment.
    Chapter 14 and 15, to describe Necrotic Enteritis Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now